Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

On This Page

All Headings will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office	ID
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development	546
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development	540
Boring, Daniel, R.Ph., Ph.D. [C] daniel.boring@nih.gov 240-276-6422		Contractor \| Chemopreventive Agent Development	1354
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E542	Deputy Chief \| Chemopreventive Agent Development	558
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E538	Program Officer \| Chemopreventive Agent Development	542
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E536	Program Officer \| Chemopreventive Agent Development	573
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E602	Program Officer \| Chemopreventive Agent Development	594
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E570	Program Officer \| Chemopreventive Agent Development	2557
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development	623
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science	624
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E546	Program Officer \| Chemopreventive Agent Development	2525

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Atigadda, Venkatram Reddy	University Of Alabama At Birmingham United States	Development of Potent and non-toxic rexinoids to prevent non-melanoma skin cancer	5R01CA276683-03
Barber, Glen N.	University Of Miami School Of Medicine United States	Development of A HTLV-1 Vaccine	5R01CA252049-04	Marjorie Perloff, M.D.
Boone, Anna	University Of Missouri-Columbia United States	Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer	1R21CA286404-01A1	Marjorie Perloff, M.D.
Buchanan, Adam H	Geisinger Clinic United States	Feasibility and Assessment of a Cascade Traceback Screening program - FACTS	5U01CA240747-04	Marjorie Perloff, M.D.
Cao, Shugeng	University Of Hawaii At Hilo United States	Discovery of novel natural TEAD inhibitors for the chemoprevention of liver tumors	5UG3CA290375-02	Altaf Mohammed, Ph.D.
Castilla, Lucio H.	Univ Of Massachusetts Med Sch Worcester United States	Study of tyrosine kinase inhibitors as preventive therapy in RUNX1-FPD	1U01CA296350-01	Marjorie Perloff, M.D.
Caulin, Carlos	University Of Arizona United States	Genetic Alterations That Confer High Risk to Oral Premalignant Lesions	5R01CA274857-03
Chiang, Cheng-Ming	Ut Southwestern Medical Center United States	Small Compound Inhibitors Targeting HPV Genome Replication	1R01CA288743-01A1
Clapper, Margie L.	Research Inst Of Fox Chase Can Ctr United States	Novel small molecule agents to correct pathogenic VHL missense mutations	3U54CA272686-03S1
Clare, Susan E.	Northwestern University At Chicago United States	Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype	1R21CA288676-01A1
Curiel-Lewandrowski, Clara	University Of Arizona United States	Targeted Prevention for Non-Melanoma Skin Cancer	5P01CA229112-05
Dashwood, Roderick H	Texas A&M University Health Science Ctr United States	Immunoepigenetic targeting of MHC regulators in FAP	5R01CA257559-03
Demehri, Shadmehr	Massachusetts General Hospital United States	Immunosurveillance of breast glands with oncogenic germline mutations	1UG3CA290300-01	Altaf Mohammed, Ph.D.
Furuta, Saori	Case Western Reserve University United States	Normalizing arginine metabolism with sepiaptein for immunostimulatory-shift ofHER2+ breast cancer	5R01CA248304-05
Garcia, Jose M.	Seattle Inst For Biomedical/Clinical Res United States	SArcopenia in Men with Prostate Cancer undergoing ADT (SAP-ADT)	5R01CA279220-02	Marjorie Perloff, M.D.